Non-invasive sleep therapy to enhance deep sleep at home
Non-Invasive At-Home Sleep Therapy System
This study is testing a new sleep device that gently stimulates the brain at home to see if it can help healthy adults get more deep sleep and improve their overall sleep quality.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 22 Years to 85 Years |
| Sex | All |
| Sponsor | Brain Electrophysiology Laboratory Company Industry-sponsored |
| Locations | 1 site (Eugene, Oregon) |
| Trial ID | NCT05970276 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of a non-invasive brain stimulation device, SleepWISP, in enhancing deep sleep and improving sleep quality in healthy adults. Participants will wear the device at home during sleep, which records brain activity and applies low-level electrical stimulation during slow-wave sleep. The study aims to replicate previous findings that suggest this stimulation can increase deep sleep duration. Participants will undergo up to three nights of sleep monitoring to assess the device's impact on their sleep patterns.
Who should consider this trial
Good fit: Ideal candidates are normally aging adults aged 22-85 who do not have significant neurological or sleep disorders.
Not a fit: Patients with a history of seizures, severe insomnia, or significant neurological diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could significantly improve sleep quality and memory in healthy adults.
How similar studies have performed: Previous pilot studies have shown promising results for similar non-invasive brain stimulation approaches in enhancing deep sleep.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Normally aging adults between the ages of 22-85 Exclusion Criteria: * History of seizures * History of epilepsy * History of brain injury or trauma (including neurosurgery) * History or presence of significant neurological disease such as Parkinson * History of Electroconvulsive Therapy (ECT) * Presence of severe insomnia * Presence of sleep apnea * Presence of severe anxiety or depression * Taking medications that may affect the EEG * History of stroke * Sensitivity or allergy to lidocaine or silver * Presence of active suicidal ideation * Presence of metal in head or implants or medication infusion device * Pregnancy * Adverse reaction to TMS
Where this trial is running
Eugene, Oregon
- Brain Electrophysiology Laboratory Company — Eugene, Oregon, United States (Recruiting)
Study contacts
- Study coordinator: Don M Tucker, PhD
- Email: don.tucker@bel.company
- Phone: 541-653-8266
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.